GB1180233A - Modified Spiramycin - Google Patents

Modified Spiramycin

Info

Publication number
GB1180233A
GB1180233A GB8043/66A GB804366A GB1180233A GB 1180233 A GB1180233 A GB 1180233A GB 8043/66 A GB8043/66 A GB 8043/66A GB 804366 A GB804366 A GB 804366A GB 1180233 A GB1180233 A GB 1180233A
Authority
GB
United Kingdom
Prior art keywords
spiramycin
products
feb
resin
flavoured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8043/66A
Other languages
English (en)
Inventor
Jean Astruc
Andre Sambot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB8043/66A priority Critical patent/GB1180233A/en
Priority to DE19671593741 priority patent/DE1593741A1/de
Priority to NL6702425A priority patent/NL6702425A/xx
Priority to LU53049D priority patent/LU53049A1/xx
Priority to BE694496D priority patent/BE694496A/xx
Publication of GB1180233A publication Critical patent/GB1180233A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GB8043/66A 1966-02-23 1966-02-23 Modified Spiramycin Expired GB1180233A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB8043/66A GB1180233A (en) 1966-02-23 1966-02-23 Modified Spiramycin
DE19671593741 DE1593741A1 (de) 1966-02-23 1967-02-17 Verfahren zur Herstellung eines Antibiotikums
NL6702425A NL6702425A (forum.php) 1966-02-23 1967-02-17
LU53049D LU53049A1 (forum.php) 1966-02-23 1967-02-22
BE694496D BE694496A (forum.php) 1966-02-23 1967-02-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8043/66A GB1180233A (en) 1966-02-23 1966-02-23 Modified Spiramycin

Publications (1)

Publication Number Publication Date
GB1180233A true GB1180233A (en) 1970-02-04

Family

ID=9844680

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8043/66A Expired GB1180233A (en) 1966-02-23 1966-02-23 Modified Spiramycin

Country Status (5)

Country Link
BE (1) BE694496A (forum.php)
DE (1) DE1593741A1 (forum.php)
GB (1) GB1180233A (forum.php)
LU (1) LU53049A1 (forum.php)
NL (1) NL6702425A (forum.php)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02111719A (ja) * 1988-05-11 1990-04-24 Glaxo Group Ltd 薬物吸着質

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02111719A (ja) * 1988-05-11 1990-04-24 Glaxo Group Ltd 薬物吸着質

Also Published As

Publication number Publication date
DE1593741A1 (de) 1970-09-03
LU53049A1 (forum.php) 1967-06-16
BE694496A (forum.php) 1967-07-31
NL6702425A (forum.php) 1967-08-24

Similar Documents

Publication Publication Date Title
CA973554A (en) 2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation
GB1436487A (en) Compositions for oral hygiene
GB1180233A (en) Modified Spiramycin
GB1326327A (en) Process for the preparation of bis-p-chlorophenoxy-acetyl-urea
IE33371L (en) Protozoacids; aminoguanidine derivatives
GB1212943A (en) 0,1,1,3,3-pentafluoro-2-propyl p-toluenesulphonate
GB1453234A (en) Liquid vehicle for pharmaceutical compositions
AU472024B2 (en) l-(3-CYANO-3, 3, DIPHENYLPROPYL)-4-PEHNYLPIP ERINE-4-CARBOXYLIC ACID DERIVATIVES
IE34609B1 (en) Antineoplastic therapeutic compositions
GB1280355A (en) Substituted 5-nitro-imidazoles and their preparation
GB1490169A (en) N-vinyloxyethyl-alpha-methyl-beta-phenethylamines
GB1247821A (en) Substituted anthraquinones
GB1440850A (en) Vaso-regulator compositions
IL45087A (en) Inhalant preparations containing 3,20-dioxo-pregn-4-enoic acid derivatives
GB1336609A (en) Antismoking preparation
GB1263839A (en) A novel aminoethanesulfonic acid
GB1395929A (en) Thioureas
GB1356991A (en) Kanamycin a salts
GB1132397A (en) Improvements in or relating to fluorene derivatives and the manufacture thereof
GB1244348A (en) Fluorene derivatives
GB1385136A (en) Process of preparing 6-azauracil
GB1174177A (en) 0,2,5-Thiadiazole Derivatives
USD199814S (en) Edwin h
GB1324300A (en) Antifungal thiocyanatobenzothiazoles
GB1264872A (forum.php)